Consistent reduction in major cardiovascular events, even beyond glycaemic effects Meaningful kidney protection, slower eGFR decline & reduced albuminuria Benefits across phenotypes: diabetes, obesity, HFpEF, CKD & ASCVD A clear shift from organ-specific treatment to system-level risk reduction The next phase feels less about whether these agents work & more about who benefits most, when to start & how to integrate them alongside SGLT2 inhibitors and standard CV therapies
Vitamin B Complex and Vitamin B12 Vitamin B complex includes a group of essential vitamins that support energy production, brain function, and cell metabolism
The related npj Aging study was also supported in part by the National Institutes of Health (grants P30 AI036214, UM1 AI068634, UM1 AI068636, UM1 AI106701) and the James B
The answer to this is that a multiplicity of scientific evidence points out that L-carnitine may not contribute to loss
Dr Jose Villamarin
GIP as a therapeutic target in diabetes and obesity: Insight from incretin co-agonists